Opponents of the measure included many physicians who said the drugs have other critical reproductive health care uses, and that changing the classification could make it harder to prescribe the drugs.
As Hunter looked on in court, Judge Maryellen Noreika ruled the "laptop from hell" could not be barred out of hand based on his legal team's claim it had been hacked and seeded with false information.
By KEVIN McGILL Associated Press NEW ORLEANS (AP) — Louisiana Gov. Jeff Landry has signed a first-of-its-kind bill to classify two abortion-inducing drugs as controlled and dangerous substances. The Republican governor announced his…
Get latest articles and stories on World at LatestLY. First-of-its-kind legislation that classifies two abortion-inducing drugs as controlled and dangerous substances has been signed into law by Louisiana Gov. Jeff Landry.
On May 21, 2024, the United States Court of Appeals for the District of Columbia Circuit (“D.C. Circuit”) issued its decision in United Therapeutics Corporation v. Carole Johnson, et al./Novartis Pharmaceuticals v. Carole Johnson …
Glenis Zapata, 34, is charged with two counts of money laundering for allegedly transporting a total of $310,000 of cocaine profits from Chicago in 2019.
Saskatoon police say officers arrested three people and seized drugs and drug paraphernalia Thursday. The trio, a man and two women, face charges related to trafficking.
While it's difficult to pinpoint the exact reasons behind substance abuse or suicide, racial inequality, economic distress and historical trauma have aggravated those problems in marginalized communities.
While it's difficult to pinpoint the exact reasons behind substance abuse or suicide, racial inequality, economic distress and historical trauma have aggravated those problems in marginalized communities.
While it's difficult to pinpoint the exact reasons behind substance abuse or suicide, racial inequality, economic distress and historical trauma have aggravated those problems in marginalized communities.
A new editorial paper was published in Oncoscience, titled "PH-binding motifs as a platform for drug design: Lessons from protease-activated receptors; PARs."